Arginine vasopressin release in response to the administration of 3,4-methylenedioxymethamphetamine (ecstasy''): is metabolism a contributory factor?
Authors: Forsling M.1; Fallon J.K.1; Kicman A.T.1; Hutt A.J.1; Cowan D.A.1; Henry J.A.1
Source: Journal of Pharmacy and Pharmacology, Volume 53, Number 10, 1 October 2001 , pp. 1357-1363(7)
Publisher: Pharmaceutical Press
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Abstract:
The aim of this investigation was to examine the effect of 3,4-methylenedioxymethamphetamine (MDMA) administration on arginine vasopressin (AVP) release. (R,S)-MDMA (40mg) was administered to eight normally hydrated healthy male volunteers (2232 years) and blood samples were collected up to 24h. Plasma was assayed for AVP and cortisol by radioimmunoassays, and for MDMA and the N-demethylated metabolite, MDA, by gas chromatography-mass spectrometry. Sodium concentrations and osmolality were also determined. Plasma AVP increased in all subjects after MDMA administration and a significant negative correlation was observed between concentrations of AVP and both single and total enantiomer MDMA at 1h (r<-0.91, P<0.01). This had disappeared by 2h (P>0.7). Compared with basal values, no significant change was observed for osmolality or cortisol at 1h after drug administration. In conclusion, plasma AVP concentrations increase after MDMA administration, but the increase is not part of a generalized stress response since cortisol did not increase concurrently. A significant negative correlation between plasma MDMA and AVP was observed soon after administration. The possibility that a pharmacological effect of MDMA is primarily mediated via one or more metabolites, rather than by the parent drug, should be considered.Document Type: Research article
DOI: 10.1211/0022357011777855
Affiliations: 1: Neuroendocrine Laboratories, New Hunts House, King's College London, Guy's Hospital, London Bridge, London, UK, SE1 1UL
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content

Click here for Page Help